title: Quantification of the response of equine apocrine sweat glands to beta2-adrenergic stimulation.
abstract: The aim of the present study was to characterise the quantitative sweating response of the horse to beta2-adrenergic stimulation. The sweating responses of 6 horses to the randomised infusion of 8 different adrenaline concentrations (0.025, 0.05, 0.075, 0.1, 0.2, 0.4, 1.0 or 2.0 microg/kg bwt/min), was investigated. Sweating rate (SR) and skin temperature (TSK) on the neck (N) and gluteal region (G), and plasma adrenaline and noradrenaline concentrations were measured. Peak SR was approximately 15 (N) and approximately 9 g/m2/min (G) during infusion of both 1.0 and 2.0 microg/kg bwt/min adrenaline. Sweat produced per nmol/l plasma adrenaline peaked during the infusion of 0.075 microg/kg bwt/min adrenaline. Higher adrenaline infusion concentrations resulted in a progressive decrease in the amount of sweat produced per nmol/l plasma adrenaline and a plateau of 6 g/m2/(nmol/l) plasma adrenaline was reached for infusions between 1.0 and 2.0 microg/kg bwt/min. Peak SR were far lower than we have previously reported during exercise. There was no evidence of sweat gland fatigue or vasoconstriction during infusion, suggesting saturation of sweat gland beta2 receptors. We conclude that sweating in the horse is under dual control from a combination of hormonal and neural mechanisms.
authors.affiliation: Centre for Equine Studies, The Animal Health Trust, Kentford, Newmarket, Suffolk, UK.
authors.forename: C M
authors.initials: CM
authors.lastname: Scott
authors.forename: D J
authors.initials: DJ
authors.lastname: Marlin
authors.forename: R C
authors.initials: RC
authors.lastname: Schroter
mesh_terms: D000318:Adrenergic beta-Agonists / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D000818:Animals; D001050:Apocrine Glands / Q000378:metabolism* / Q000502:physiology; D001798:Blood Proteins / Q000032:analysis; D001831:Body Temperature / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004573:Electrolytes / Q000097:blood; D004837:Epinephrine / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D005260:Female; D006736:Horses / Q000502:physiology*; D007262:Infusions, Intravenous / Q000662:veterinary; D008297:Male; D011897:Random Allocation; D012881:Skin Temperature / Q000187:drug effects* / Q000502:physiology; D013542:Sweat / Q000378:metabolism; D013546:Sweating / Q000187:drug effects* / Q000502:physiology; D013997:Time Factors
chemical_list: D000318:Adrenergic beta-Agonists; D001798:Blood Proteins; D004573:Electrolytes; D004837:Epinephrine